KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Net Margin (2016 - 2025)

Historic Net Margin for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to 1.19%.

  • AbbVie's Net Margin fell 96200.0% to 1.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.02%, marking a year-over-year decrease of 52300.0%. This contributed to the annual value of 7.61% for FY2024, which is 13600.0% down from last year.
  • AbbVie's Net Margin amounted to 1.19% in Q3 2025, which was down 96200.0% from 6.1% recorded in Q2 2025.
  • In the past 5 years, AbbVie's Net Margin ranged from a high of 33.19% in Q1 2022 and a low of 0.15% during Q4 2024
  • Its 5-year average for Net Margin is 13.04%, with a median of 10.82% in 2024.
  • Its Net Margin has fluctuated over the past 5 years, first skyrocketed by 270500bps in 2021, then plummeted by -312200bps in 2023.
  • AbbVie's Net Margin (Quarter) stood at 27.17% in 2021, then plummeted by -40bps to 16.35% in 2022, then plummeted by -65bps to 5.76% in 2023, then tumbled by -103bps to 0.15% in 2024, then surged by 882bps to 1.19% in 2025.
  • Its Net Margin was 1.19% in Q3 2025, compared to 6.1% in Q2 2025 and 9.66% in Q1 2025.